Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 1:28 PM
Ignite Modification Date:
2025-12-24 @ 1:28 PM
NCT ID:
NCT00388895
Brief Summary:
% positive Ph LLA with RC alter the Glivec and induction chemotherapy treatment
Detailed Description:
Pilot phase II clinical trial, prospective, multicentric and opened
Study:
NCT00388895
Study Brief:
Protocol Section:
NCT00388895